Cargando…

ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort

BACKGROUND: Zinc finger and BTB domain-containing protein 12 (ZBTB12) is a predicted transcription factor with potential role in hematopoietic development. Recent evidence linked low methylation level of ZBTB12 exon1 to myocardial infarction (MI) risk. However, the role of ZBTB12 in the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Noro, Fabrizia, Gianfagna, Francesco, Gialluisi, Alessandro, De Curtis, Amalia, Di Castelnuovo, Augusto, Napoleone, Emanuela, Cerletti, Chiara, Donati, Maria Benedetta, de Gaetano, Giovanni, Hoylaerts, Marc F., Iacoviello, Licia, Izzi, Benedetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511189/
https://www.ncbi.nlm.nih.gov/pubmed/31077224
http://dx.doi.org/10.1186/s13148-019-0665-6
_version_ 1783417537794408448
author Noro, Fabrizia
Gianfagna, Francesco
Gialluisi, Alessandro
De Curtis, Amalia
Di Castelnuovo, Augusto
Napoleone, Emanuela
Cerletti, Chiara
Donati, Maria Benedetta
de Gaetano, Giovanni
Hoylaerts, Marc F.
Iacoviello, Licia
Izzi, Benedetta
author_facet Noro, Fabrizia
Gianfagna, Francesco
Gialluisi, Alessandro
De Curtis, Amalia
Di Castelnuovo, Augusto
Napoleone, Emanuela
Cerletti, Chiara
Donati, Maria Benedetta
de Gaetano, Giovanni
Hoylaerts, Marc F.
Iacoviello, Licia
Izzi, Benedetta
author_sort Noro, Fabrizia
collection PubMed
description BACKGROUND: Zinc finger and BTB domain-containing protein 12 (ZBTB12) is a predicted transcription factor with potential role in hematopoietic development. Recent evidence linked low methylation level of ZBTB12 exon1 to myocardial infarction (MI) risk. However, the role of ZBTB12 in the pathogenesis of MI and cardiovascular disease in general is not yet clarified. We investigated the relation between ZBTB12 methylation and several blood parameters related to cardio-cerebrovascular risk in an Italian family-based cohort. RESULTS: ZBTB12 methylation was analyzed on white blood cells from the Moli-family cohort using the Sequenom EpiTYPER MassARRAY (Agena). A total of 13 CpG Sequenom units were analyzed in the small CpG island located in the only translated ZBTB12 exon. Principal component analysis (PCA) was performed to identify groups of CpG units with similar methylation estimates. Linear mixed effect regressions showed a positive association between methylation of ZBTB12 Factor 2 (including CpG units 8, 9–10, 16, 21) and TNF-ɑ stimulated procoagulant activity, a measure of procoagulant and inflammatory potential of blood cells. In addition, we also found a negative association between methylation of ZBTB12 Factor 1 (mainly characterized by CpG units 1, 3–4, 5, 11, and 26) and white blood cell and granulocyte counts. An in silico prediction analysis identified granulopoiesis- and hematopoiesis-specific transcription factors to potentially bind DNA sequences encompassing CpG1, CpG3–4, and CpG11. CONCLUSIONS: ZBTB12 hypomethylation is linked to shorter TNF-ɑ stimulated whole blood coagulation time and increased WBC and granulocyte counts, further elucidating the possible link between ZBTB12 methylation and cardiovascular disease risk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0665-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6511189
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65111892019-05-20 ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort Noro, Fabrizia Gianfagna, Francesco Gialluisi, Alessandro De Curtis, Amalia Di Castelnuovo, Augusto Napoleone, Emanuela Cerletti, Chiara Donati, Maria Benedetta de Gaetano, Giovanni Hoylaerts, Marc F. Iacoviello, Licia Izzi, Benedetta Clin Epigenetics Research BACKGROUND: Zinc finger and BTB domain-containing protein 12 (ZBTB12) is a predicted transcription factor with potential role in hematopoietic development. Recent evidence linked low methylation level of ZBTB12 exon1 to myocardial infarction (MI) risk. However, the role of ZBTB12 in the pathogenesis of MI and cardiovascular disease in general is not yet clarified. We investigated the relation between ZBTB12 methylation and several blood parameters related to cardio-cerebrovascular risk in an Italian family-based cohort. RESULTS: ZBTB12 methylation was analyzed on white blood cells from the Moli-family cohort using the Sequenom EpiTYPER MassARRAY (Agena). A total of 13 CpG Sequenom units were analyzed in the small CpG island located in the only translated ZBTB12 exon. Principal component analysis (PCA) was performed to identify groups of CpG units with similar methylation estimates. Linear mixed effect regressions showed a positive association between methylation of ZBTB12 Factor 2 (including CpG units 8, 9–10, 16, 21) and TNF-ɑ stimulated procoagulant activity, a measure of procoagulant and inflammatory potential of blood cells. In addition, we also found a negative association between methylation of ZBTB12 Factor 1 (mainly characterized by CpG units 1, 3–4, 5, 11, and 26) and white blood cell and granulocyte counts. An in silico prediction analysis identified granulopoiesis- and hematopoiesis-specific transcription factors to potentially bind DNA sequences encompassing CpG1, CpG3–4, and CpG11. CONCLUSIONS: ZBTB12 hypomethylation is linked to shorter TNF-ɑ stimulated whole blood coagulation time and increased WBC and granulocyte counts, further elucidating the possible link between ZBTB12 methylation and cardiovascular disease risk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0665-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-10 /pmc/articles/PMC6511189/ /pubmed/31077224 http://dx.doi.org/10.1186/s13148-019-0665-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Noro, Fabrizia
Gianfagna, Francesco
Gialluisi, Alessandro
De Curtis, Amalia
Di Castelnuovo, Augusto
Napoleone, Emanuela
Cerletti, Chiara
Donati, Maria Benedetta
de Gaetano, Giovanni
Hoylaerts, Marc F.
Iacoviello, Licia
Izzi, Benedetta
ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title_full ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title_fullStr ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title_full_unstemmed ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title_short ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort
title_sort zbtb12 dna methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the moli-family cohort
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511189/
https://www.ncbi.nlm.nih.gov/pubmed/31077224
http://dx.doi.org/10.1186/s13148-019-0665-6
work_keys_str_mv AT norofabrizia zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT gianfagnafrancesco zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT gialluisialessandro zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT decurtisamalia zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT dicastelnuovoaugusto zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT napoleoneemanuela zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT cerlettichiara zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT donatimariabenedetta zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT degaetanogiovanni zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT hoylaertsmarcf zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT iacoviellolicia zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT izzibenedetta zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort
AT zbtb12dnamethylationisassociatedwithcoagulationandinflammationrelatedbloodcellparametersfindingsfromthemolifamilycohort